Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Colorectal cancer: CRC--all about microbial products and barrier function?

Literature DB >> 23165234

Colorectal cancer: CRC--all about microbial products and barrier function?

Christian Jobin.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23165234 PMCID： PMC3612125 DOI： 10.1038/nrgastro.2012.220

Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802

× No keyword cloud information.

10 in total

1. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Authors: Nina Sanapareddy; Ryan M Legge; Biljana Jovov; Amber McCoy; Lauren Burcal; Felix Araujo-Perez; Thomas A Randall; Joseph Galanko; Andrew Benson; Robert S Sandler; John F Rawls; Zaid Abdo; Anthony A Fodor; Temitope O Keku
Journal: ISME J Date: 2012-05-24 Impact factor: 10.302

2. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

Authors: Mauro Castellarin; René L Warren; J Douglas Freeman; Lisa Dreolini; Martin Krzywinski; Jaclyn Strauss; Rebecca Barnes; Peter Watson; Emma Allen-Vercoe; Richard A Moore; Robert A Holt
Journal: Genome Res Date: 2011-10-18 Impact factor: 9.043

3. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors: Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal: Genome Res Date: 2011-10-18 Impact factor: 9.043

Review 4. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention.

Authors: Charlotte R Hedin; Andrew J Stagg; Kevin Whelan; James O Lindsay
Journal: Gut Date: 2011-05-11 Impact factor: 23.059

5. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors: Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal: Nature Date: 2012-11-08 Impact factor: 49.962

6. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Authors: Grace Y Chen; Michael H Shaw; Gloria Redondo; Gabriel Núñez
Journal: Cancer Res Date: 2008-12-15 Impact factor: 12.701

Review 7. Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis.

Authors: Yun Tian; Yi Li; Zhenhua Hu; Daqing Wang; Xiyang Sun; Changshan Ren
Journal: Int J Colorectal Dis Date: 2009-09-29 Impact factor: 2.571

8. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

Authors: Xiang Jun Shen; John F Rawls; Thomas Randall; Lauren Burcal; Caroline N Mpande; Natascha Jenkins; Biljana Jovov; Zaid Abdo; Robert S Sandler; Temitope O Keku
Journal: Gut Microbes Date: 2010-05-13

9. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

Authors: Masayuki Fukata; Anli Chen; Arunan S Vamadevan; Jason Cohen; Keith Breglio; Suneeta Krishnareddy; David Hsu; Ruliang Xu; Noam Harpaz; Andrew J Dannenberg; Kotha Subbaramaiah; Harry S Cooper; Steven H Itzkowitz; Maria T Abreu
Journal: Gastroenterology Date: 2007-09-14 Impact factor: 22.682

10. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides.

Authors: A L Frantz; E W Rogier; C R Weber; L Shen; D A Cohen; L A Fenton; M E C Bruno; C S Kaetzel
Journal: Mucosal Immunol Date: 2012-04-11 Impact factor: 7.313

10 in total

18 in total

Review 1. The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors: N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal: Curr Gastroenterol Rep Date: 2013-09

2. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors: Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal: Cell Host Microbe Date: 2013-08-14 Impact factor: 21.023

10. Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature.

Authors: Jae M Shin; Ting Luo; Pachiyappan Kamarajan; J Christopher Fenno; Alexander H Rickard; Yvonne L Kapila
Journal: Sci Rep Date: 2017-08-30 Impact factor: 4.379

Colorectal cancer: CRC--all about microbial products and barrier function?

1. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

2. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

3. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Review 4. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention.

5. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

6. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Review 7. Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis.

8. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

9. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

10. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides.

Review 1. The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

2. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Review 3. Microbes, microbiota, and colon cancer.

Review 4. Host immune response to infection and cancer: unexpected commonalities.

Review 5. The therapeutic value of targeting inflammation in gastrointestinal cancers.

Review 6. MyD88 and its divergent toll in carcinogenesis.

Review 7. Role of lung and gut microbiota on lung cancer pathogenesis.

8. Polymorphisms in the CHIT1 gene: Associations with colorectal cancer.

Review 9. Next-generation sequencing: recent applications to the analysis of colorectal cancer.

10. Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature.